Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

Spironolactone most effective for hirsutism, but has side effects.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

A new gene, JMJD1C, may affect testosterone levels in men.

Targeting the skin's endocannabinoid system could help treat skin disorders.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Iron deficiency common in women, not always linked to hair loss; more research needed.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Doctors need to be better prepared to assess and treat obesity in patients.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.